Methocarbamol and Epilepsy aggravated - a phase IV clinical study of FDA data

Summary:

Epilepsy aggravated is reported as a side effect among people who take Methocarbamol (methocarbamol), especially for people who are male, 30-39 old, also take Fish Oil, and have Quit smoking.

The phase IV clinical study analyzes which people have Epilepsy aggravated when taking Methocarbamol. It is created by eHealthMe based on reports of 16,788 people who have side effects when taking Methocarbamol from the FDA, and is updated regularly.

What is Methocarbamol?

Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 17,766 Methocarbamol users. Check the latest studies of Methocarbamol.

What is Epilepsy aggravated?

Epilepsy aggravated (serious common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,071 drugs and 456 conditions by eHealthMe. Check the latest studies of Epilepsy aggravated.

On Jul, 15, 2026

16,788 people reported to have side effects when taking Methocarbamol.
Among them, 25 people (0.15%) have Epilepsy aggravated.

Could Methocarbamol cause Epilepsy aggravated?

Among these 25 people:

What is the gender of people who have Epilepsy aggravated when taking Methocarbamol? *

female: 42.11 %
male: 57.89 %

What is the age of people who have Epilepsy aggravated when taking Methocarbamol? *

What are other drugs people take besides Methocarbamol? *

Fish Oil: 13 people, 52.00%
Pantoprazole: 8 people, 32.00%
Acetaminophen: 6 people, 24.00%
Sodium Chloride: 5 people, 20.00%
Hydroxyzine Hydrochloride: 5 people, 20.00%
Magnesium: 5 people, 20.00%
Heparin: 5 people, 20.00%
Metoprolol Succinate: 5 people, 20.00%
Fluoxetine Hydrochloride: 5 people, 20.00%
Ondansetron: 5 people, 20.00%

What are other side effects people have besides Epilepsy aggravated? *

Fatigue (feeling of tiredness): 9 people, 36.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 8 people, 32.00%
Weakness: 7 people, 28.00%
Tardive Dyskinesia (a disorder that involves involuntary movements): 7 people, 28.00%
Dizziness: 6 people, 24.00%
Abdominal Pain: 5 people, 20.00%
Headache (pain in head): 5 people, 20.00%
Postural Orthostatic Tachycardia Syndrome (abnormal increase in heart rate on becoming upright): 5 people, 20.00%
Gastric Ulcer (stomach ulcer): 5 people, 20.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 20.00%

What are the existing conditions these people have? *

Quit Smoking: 9 people, 36.00%
Affective Disorder (mental disorder): 8 people, 32.00%
Akathisia (a movement disorder characterized by a feeling of inner restlessness): 8 people, 32.00%
Psychotic Disorder: 8 people, 32.00%
Drooling (drop saliva uncontrollably from the mouth): 8 people, 32.00%
Nightmares (unpleasant dreams): 8 people, 32.00%
Immunodeficiency Common Variable: 5 people, 20.00%
Malignant Melanoma (skin cancer rises from melancytes): 4 people, 16.00%
Schizoaffective Disorder Bipolar Type (mental illness featuring schizophrenia and a mood disorder with mania): 3 people, 12.00%
Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Methocarbamol and have Epilepsy aggravated?

- Check whether Epilepsy aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methocarbamol:

Methocarbamol (17,766 reports)

Browse all side effects of Methocarbamol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epilepsy aggravated:

Epilepsy aggravated (1,072 drugs)

Browse all the conditions that are associated with Epilepsy aggravated:

Epilepsy aggravated (456 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Methocarbamol) and Methocarbamol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.